| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry (medical) | 63 / 78 | 19th | Q4 |
| Cancer Research | 210 / 233 | 10th | Q4 |
| Biochemistry | 417 / 448 | 7th | Q4 |
| Molecular Biology | 390 / 414 | 5th | Q4 |
| Genetics | 338 / 357 | 5th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
RNA Technologies
RNA Technologies is Scopus-indexed (Q4, CiteScore 0.8). Published by Springer Medizin.
Checked against the index lists dated .
ISSN 2197-9731Verify ISSN ↗2197-9758Verify ISSN ↗
Publisher: Springer Medizin
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is RNA Technologies indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2010–2025, best quartile Q4, CiteScore 0.8.
What quartile is RNA Technologies in Scopus?
RNA Technologies is Q4 in Biochemistry (medical) (rank 63 of 78), Q4 in Cancer Research (rank 210 of 233) and Q4 in Biochemistry (rank 417 of 448), by CiteScore 2025. It is ranked in 5 subject areas in all.
What is the impact factor of RNA Technologies?
RNA Technologies is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.8, quartile Q4, 19th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Who publishes RNA Technologies and what is its ISSN?
RNA Technologies is published by Springer Medizin. Its print ISSN is 2197-9731 and its online ISSN is 2197-9758.
Is RNA Technologies in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is RNA Technologies open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is RNA Technologies? — open metrics via OpenAlex
RNA Technologies has an h-index of 16 and a 2-year mean of 0.21 citations per paper (OpenAlex). Its Scopus CiteScore is 0.8, quartile Q4. On 2-year citations it ranks #64 of 77 Scopus journals in Biochemistry (medical).
RNA Technologies published 17 papers in 2025; its busiest recent year was 2023 with 30. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for RNA Technologies? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.